NextCure Balance Sheet Health
Financial Health criteria checks 6/6
NextCure has a total shareholder equity of $75.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $90.3M and $14.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$75.31m |
| Equity | US$75.59m |
| Total liabilities | US$14.75m |
| Total assets | US$90.35m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2US's short term assets ($78.7M) exceed its short term liabilities ($8.7M).
Long Term Liabilities: 2US's short term assets ($78.7M) exceed its long term liabilities ($6.1M).
Debt to Equity History and Analysis
Debt Level: 2US is debt free.
Reducing Debt: 2US has no debt compared to 5 years ago when its debt to equity ratio was 2.9%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2US has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 2US has sufficient cash runway for 2.1 years if free cash flow continues to reduce at historical rates of 17.2% each year.